ZyVersa Therapeutics (ZVSA) Live Share Price, Invest From India

ZyVersa Therapeutics Stock Performance

as on September 4, 2026 at 2:07 am IST

Day's High
$0.10
Day's Price Range
$0.11
$0.10
10.00%
Upside
52 Week's Low
52 Week's High
$0.08
52-Week Price Range
$0.30
$0.10
22.60%
Downside
200.00%
Upside

ZyVersa Therapeutics share price movements today

Previous Close: $0.10
Open: $0.10
Volume: 240.6K
Market Cap: $801.5K
Day's Low - High: $0.10 - $0.11
52 Week Low - High: $0.08 - $0.30

ZyVersa Therapeutics Historical Returns

1 Month Return: -1.98 %
3 Month Return: -41.76 %
1 Year Return: -17.64 %
3 Year Return: -99.8 %
5 Year Return: 0 %

ZyVersa Therapeutics Stock Fundamentals & Key Indicators

Check ZyVersa Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$801.5K

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-6.8M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-112.65%

ZyVersa Therapeutics stock Key Stats

Compare market cap, revenue, PE, and other key metrics of ZyVersa Therapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
ZyVersa Therapeutics	BUY	$801.5K	NA	NA	0.00%	NA

Stock Returns calculator for ZyVersa Therapeutics Stock including INR - Dollar returns

The ZyVersa Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

ZyVersa Therapeutics investment value today

Current value as on today

₹89,242

Returns

-₹10,758

(-10.76%)

Returns from ZyVersa Therapeutics Stock

-₹16,805 (-16.81%)

Dollar Impact

₹6,047 (+6.05%)

Analyst Recommendation on ZyVersa Therapeutics Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for ZyVersa Therapeutics. Average target price of $20

ZyVersa Therapeutics Share Price Target

Get share price movements and forecasts by analysts on ZyVersa Therapeutics.

What analysts predicted

99.5%UPSIDE

Target Price

$20

Current Price

$0.1

Analyzed by

8 Analysts

Target

$20.00

ZyVersa Therapeutics target price $20, a slight upside of 99.5% compared to current price of $0.1. According to 8 analysts rating.

ZyVersa Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	0	0	-	-	0	-	-	-	-	-
Gross Profit	0	0	0	0	0	-	-	-	-	-
Operating Income	-1	-2	-2	-2	-1	-2,144	-2,044	-2	4,183	-1
EBITDA	-95	-2	-2	-2	-1	-2	-2	-20	0	-1
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	-	-	-	-	-	-
Income Before Tax	-13	-2	-2	-2	-1	-2,256	-2,211	-20	4,463	-1
Income Tax Expense	0	0	0	-	0	-	-	0	-	-
Net Income	-13	-2	-2	-2	-1	-2	-2	-19	0	-1
Net Profit Margin	-85503.21%	-18120.11%	0.00%	0.00%	-5451.72%	0.00%	0.00%	0.00%	0.00%	0.00%

ZyVersa Therapeutics Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	-
Operating Income	-11	-7	-13	-14	-9,136	-6
EBITDA	-12	-7	-14	-107	-9,136	-25
Interest Expense	0	0	0	0	0	0
Depreciation	0	0	0	0	0	-
Income Before Tax	-12	-8	-14	-107	-9,420	-25
Income Tax Expense	0	0	0	-9	-6	0
Net Income	-12	-8	-14	-98	-9,413	-24
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

ZyVersa Therapeutics Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-2	-2	-2	-1	-2	-2	-19,805	1,576	-1,793
Operating Cash Flow	-3	-1	0	-1	-1,772	-1	-1,406	-413	-799
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	2	-	0	2	1,852	-17	1,862	-12	1,000
Change in Cash	-1	-1	0	1	80	-1	455	-426	200

ZyVersa Therapeutics Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-8	-14	-98	-9	-24
Operating Cash Flow	-5	-4	-8	-7	-5
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	5	1	5	5	3
Change in Cash	0	5	-2	-1	-1

About ZyVersa Therapeutics

ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It develops drug development platforms, including Cholesterol Efflux Mediator VAR 200, an injectable drug, which is in Phase 2a clinical trial for the treatment of renal indications, such as focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney diseases; and Inflammasome ASC Inhibitor IC 100 a humanized monoclonal antibody inflammasome ASC inhibitor in preclinical development for the treatment of numerous inflammatory diseases, with cardiometabolic conditions associated with obesity as the lead. The company has a license agreement with L&F Research LLC, and InflamaCORE, LLC. ZyVersa Therapeutics, Inc. was founded in 2014 and is based in Weston, Florida.

Organisation	ZyVersa Therapeutics
Headquarters	2200 N. Commerce Parkway, Weston, FL, United States, 33326
Industry	Biotechnology
CEO	Mr. Stephen C. Glover
E-voting on shares	Click here to vote

Key Management of ZyVersa Therapeutics

Name	Title
Mr. Peter Wolfe	CFO & Secretary
Ms. Karen A. Cashmere	Chief Commercial Officer
Mr. Stephen C. Glover	Co-Founder, Chairman, CEO & President

FAQs

What is ZyVersa Therapeutics share price today?

ZyVersa Therapeutics share price today is $0.10 as on September 3, 2026 at 8:37 pm IST at the close of the market. ZyVersa Therapeutics share today touched a day high of $0.11 and a low of $0.10.

What is the 52 week high and 52 week low for ZyVersa Therapeutics share?

ZyVersa Therapeutics share touched a 52 week high of $0.30 on January 12, 2026 and a 52 week low of $0.08 on August 19, 2026. ZyVersa Therapeutics stock price today i.e. September 3, 2026 at 8:37 pm IST is closed at $0.10,which is 66.67% down from its 52 week high and 29.20% up from its 52 week low.

What is ZyVersa Therapeutics's market capitalisation today?

ZyVersa Therapeutics market capitalisation is $0.00T as on September 3, 2026 at 8:37 pm IST.

How to invest in ZyVersa Therapeutics Stock (ZVSA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for ZyVersa Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in ZyVersa Therapeutics Shares that will get you 15.0000 shares as per ZyVersa Therapeutics share price of $0.10 per share as on September 3, 2026 at 8:37 pm IST.

What is the minimum amount required to buy ZyVersa Therapeutics Stock (ZVSA) from India?

Indian investors can start investing in ZyVersa Therapeutics (ZVSA) shares with as little as ₹94.475 or $1 (as of September 4, 2026 at 8:53 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹944.75 in ZyVersa Therapeutics stock (as per the Rupee-Dollar exchange rate as on September 4, 2026 at 8:53 am IST). Based on ZyVersa Therapeutics share’s latest price of $0.10 as on September 3, 2026 at 8:37 pm IST, you will get 100.0000 shares of ZyVersa Therapeutics. Learn more about fractional shares .